Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Interest Expenses (2025)

Historic Interest Expenses for Editas Medicine (EDIT) over the last 1 years, with Q3 2025 value amounting to $2.4 million.

  • Editas Medicine's Interest Expenses changed N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of -$34000.0 for FY2014, which is N/A changed from last year.
  • Per Editas Medicine's latest filing, its Interest Expenses stood at $2.4 million for Q3 2025.
  • Editas Medicine's 5-year Interest Expenses high stood at $2.4 million for Q3 2025, and its period low was $2.0 million during Q2 2025.